Finance

Fidson announces strategic cooperation with Chinese pharmaceutical firm

Fidson

In a bid to further add value to the healthcare landscape in Nigeria and Africa, Fidson Healthcare Plc and Jiangsu Aidea Pharmaceutical Co., Ltd in China have officially signed a strategic cooperation agreement in Yangzhou, China.Ezoic

The agreement aims to promote and address medical challenges through the use of innovative drugs especially in the treatment of over 1.9 million HIV-infected people in Nigeria.

The two companies agreed to share and combine their respective resources, technical expertise and positions in the market to collaborate on project development, market expansion, and other aspects by integrating their competitive advantages in the pharmaceutical field. Both companies will engage in multi-level and multi-form cooperation, including but not limited to product manufacturing, promotions and sales, and clinical research, involving existing products and pipeline projects.

Read:  Naira exchange rates January 2023

At the signing ceremony, Dr. Heliang Fu, Chairman of Aidea Pharma, said,: “This collaboration marks an important step for Aidea Pharma in its commitment to global medical cooperation. By integrating our expertise and experience in the field of innovative drugs, we are confident in bringing greater well-being to African patients.”

Read:  Naira Swap: CBN portal for old notes still open

Dr. Fidelis A. Ayebae, Managing Director and CEO of Fidson, on his part said: “We are eagerly looking forward to this collaboration and we believe that the complementary strengths of both parties will inject new vitality into the medical field in Africa. This is also in line with our commitment, to provide better and more accessible medicines for the people of Africa.”

The collaboration holds promise as a significant growth driver for both companies, particularly as a major factor in the development of local pharmaceutical manufacturing in Nigeria. It will also improve the healthcare and medical practice on the continent. It is expected to be a sterling example of in-depth cooperation in the medical field between China and Nigeria.

Read:  Ardova raises N25.3bn bonds under its N60bn debt issuance programme

Sunnews

Related posts

Fitch affirms sterling bank’s ‘B-’ rating

NigGal

Financial times lists Mutual Benefits among fastest growing companies

NigGal

Access, First Bank others begin PTA/BTA disbursement with dollar cards

NigGal

Google to invest $1bn in Nigeria, South Africa, others for digital economy

NigGal

AIICO bags 2021 BAFI awards

NigGal

Customers lament poor circulation of new banknotes

NigGal

Leave a Comment